We are:

• Clinical Stage Biotechnology Company Specializing in Human Vaccines
• Creating, Developing, Manufacturing & Testing Innovative HIV/AIDS Vaccines
• Conducting Multiple Site Phase 1 HIV/AIDS Human Clinical Vaccine Trials

Our AIDS Vaccines:

• Are Designed for Predominant AIDS Virus Subtypes
• Use DNA & Viral Vector Technologies
• Demonstrated Excellent Preclinical Data: 96% Protection in Non-Human Primates
• Completed Satisfactory Phase 1 Human Trial
• DNA & MVA Human Trials Stimulating Immune Responses

Our Business:

• Vaccines: The Most Cost Effective Way to Combat Infectious Disease
• Large Global AIDS Vaccine Market = >$4 Billion
• Customers: Humans - All Ages, Sexes, Races, Nationalities, Geographical Regions
• People with AIDS in 2006 is estimated at 39.5 Million